Literature DB >> 31559988

A supramolecular hydrogel to boost the production of antibodies for phosphorylated proteins.

Youzhi Wang1, Xinxin Li2, Yiming Zhang2, Ling Wang3, Zhimou Yang1.   

Abstract

Antibodies are widely used both in clinical practice and in research. However, the development of methods to increase the ratio of antibodies to recognize phosphorylated proteins remains challenging. In this study, we report a novel and useful method for the efficient production of antibodies for phosphorylated proteins. Based on our previously developed vaccine adjuvant Nap-GDFDFDY, we prepared hydrogels by the Ca2+-induced self-assembly of a phosphorylated peptide gelator Nap-GDFDFpDY. The hydrogel could protect phosphorylated antigens from being dephosphorylated by endogenous phosphatase, thus selectively increasing the ratio of the antibodies for phosphorylated proteins. Our study provides a useful strategy for the production of antibodies to recognize proteins with specific posttranslational modifications.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31559988     DOI: 10.1039/c9cc05633e

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  3 in total

Review 1.  Enzymatic Noncovalent Synthesis.

Authors:  Hongjian He; Weiyi Tan; Jiaqi Guo; Meihui Yi; Adrianna N Shy; Bing Xu
Journal:  Chem Rev       Date:  2020-08-19       Impact factor: 60.622

2.  Supramolecular Hydrogel-Wrapped Gingival Mesenchymal Stem Cells in Cutaneous Radiation Injury.

Authors:  Shasha Nie; Chunhua Ren; Xin Liang; Hui Cai; Hao Sun; Fengting Liu; Kaihua Ji; Yan Wang; Qiang Liu
Journal:  Cells       Date:  2022-09-30       Impact factor: 7.666

3.  Targeting CAMKII to reprogram tumor-associated macrophages and inhibit tumor cells for cancer immunotherapy with an injectable hybrid peptide hydrogel.

Authors:  Xiaomeng Dai; Jingshu Meng; Suke Deng; Lingling Zhang; Chao Wan; Lisen Lu; Jing Huang; Yan Hu; Zhanjie Zhang; Yan Li; Jonathan F Lovell; Gang Wu; Kunyu Yang; Honglin Jin
Journal:  Theranostics       Date:  2020-02-10       Impact factor: 11.556

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.